152 related articles for article (PubMed ID: 32700755)
21. Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells.
Qu M; Zhou Z; Chen C; Li M; Pei L; Yang J; Wang Y; Li L; Liu C; Zhang G; Yu Z; Wang D
Neurosci Res; 2012 Jan; 72(1):94-102. PubMed ID: 22001761
[TBL] [Abstract][Full Text] [Related]
22. Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in
Wu PK; Hong SK; Park JI
Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674184
[TBL] [Abstract][Full Text] [Related]
23. A proteomic screen with Drosophila Opa1-like identifies Hsc70-5/Mortalin as a regulator of mitochondrial morphology and cellular homeostasis.
Banerjee S; Chinthapalli B
Int J Biochem Cell Biol; 2014 Sep; 54():36-48. PubMed ID: 24998521
[TBL] [Abstract][Full Text] [Related]
24. Restoration of p53 functions by suppression of mortalin-p53 sequestration: an emerging target in cancer therapy.
Shankaranarayana AH; Meduri B; Pujar GV; Hariharapura RC; Sethu AK; Singh M; Bidye D
Future Med Chem; 2023 Nov; 15(22):2087-2112. PubMed ID: 37877348
[TBL] [Abstract][Full Text] [Related]
25. Human mitochondrial Hsp70 (mortalin): shedding light on ATPase activity, interaction with adenosine nucleotides, solution structure and domain organization.
Dores-Silva PR; Barbosa LR; Ramos CH; Borges JC
PLoS One; 2015; 10(1):e0117170. PubMed ID: 25615450
[TBL] [Abstract][Full Text] [Related]
26. Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma.
Xu M; Jin T; Chen L; Zhang X; Zhu G; Wang Q; Lin Z
Gene; 2019 May; 696():63-71. PubMed ID: 30776464
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor-1 interacts with the glucose-regulated protein GRP75/mortalin.
Mizukoshi E; Suzuki M; Loupatov A; Uruno T; Hayashi H; Misono T; Kaul SC; Wadhwa R; Imamura T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):461-6. PubMed ID: 10510314
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.
Park SJ; Shin JH; Jeong JI; Song JH; Jo YK; Kim ES; Lee EH; Hwang JJ; Lee EK; Chung SJ; Koh JY; Jo DG; Cho DH
J Biol Chem; 2014 Jan; 289(4):2195-204. PubMed ID: 24324263
[TBL] [Abstract][Full Text] [Related]
29. Thermal aggregates of human mortalin and Hsp70-1A behave as supramolecular assemblies.
Kiraly VTR; Dores-Silva PR; Serrão VHB; Cauvi DM; De Maio A; Borges JC
Int J Biol Macromol; 2020 Mar; 146():320-331. PubMed ID: 31899237
[TBL] [Abstract][Full Text] [Related]
30. NF-κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin.
Li S; Lv M; Qiu S; Meng J; Liu W; Zuo J; Yang L
J Cell Mol Med; 2019 Jun; 23(6):4338-4348. PubMed ID: 30983127
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus.
Yoo JY; Ryu J; Gao R; Yaguchi T; Kaul SC; Wadhwa R; Yun CO
J Gene Med; 2010 Jul; 12(7):586-95. PubMed ID: 20603860
[TBL] [Abstract][Full Text] [Related]
32. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
[TBL] [Abstract][Full Text] [Related]
33. TGR5 promotes cholangiocarcinoma by interacting with mortalin.
Li AD; Xie XL; Qi W; Wang WB; Ma JJ; Zhao DQ; Jiang XY; Chen L; Bai Y; Jiang HQ
Exp Cell Res; 2020 Apr; 389(2):111855. PubMed ID: 31978385
[TBL] [Abstract][Full Text] [Related]
34. Peptide-based tumor inhibitor encoding mitochondrial p14(ARF) is highly efficacious to diverse tumors.
Saito K; Iioka H; Kojima C; Ogawa M; Kondo E
Cancer Sci; 2016 Sep; 107(9):1290-301. PubMed ID: 27317619
[TBL] [Abstract][Full Text] [Related]
35. Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.
Lu WJ; Lee NP; Kaul SC; Lan F; Poon RT; Wadhwa R; Luk JM
Cell Death Differ; 2011 Jun; 18(6):1046-56. PubMed ID: 21233847
[TBL] [Abstract][Full Text] [Related]
36. In silico analysis of the binding properties of solasonine to mortalin and p53, and in vitro pharmacological studies of its apoptotic and cytotoxic effects on human HepG2 and Hep3b hepatocellular carcinoma cells.
Pham MQ; Tran THV; Pham QL; Gairin JE
Fundam Clin Pharmacol; 2019 Aug; 33(4):385-396. PubMed ID: 30628118
[TBL] [Abstract][Full Text] [Related]
37. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
38. Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
Jubran R; Kocsis J; Garam N; Maláti É; Gombos T; Barabás L; Gráf L; Prohászka Z; Fishelson Z
Int J Cancer; 2017 Dec; 141(11):2329-2335. PubMed ID: 28791678
[TBL] [Abstract][Full Text] [Related]
39. Critical Role of Mortalin/GRP75 in Endothelial Cell Dysfunction Associated with Acute Lung Injury.
Leonard A; Su PY; Yule DI; Rahman A; Fazal F
Shock; 2020 Aug; 54(2):245-255. PubMed ID: 31490354
[TBL] [Abstract][Full Text] [Related]
40. Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.
Wadhwa R; Ryu J; Ahn HM; Saxena N; Chaudhary A; Yun CO; Kaul SC
J Biol Chem; 2015 Mar; 290(13):8447-56. PubMed ID: 25645922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
